When was Kernel founded?

Kernel was founded in 2016 and raised its 1st funding round within a year of its incorporation.

Where is Kernel located?

Kernel is headquartered in Los Angeles, United States.

How many employees does Kernel have?

As of Jul 31, 2026, the latest employee count at Kernel is 60.

Is Kernel a funded company?

Kernel is a funded company, having raised a total of $158M across 3 funding rounds to date. The company's 1st funding round was a $***** Angel round, raised on Oct 20, 2016.

When was the latest funding round of Kernel?

Kernel's latest funding was a $***** Series C round on Nov 21, 2023, with participation from 0 investor.

Where does Kernel rank among its competitors?

Kernel ranks 7th amongst 148 active competitors, of which 45 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Neuralink, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Kernel?

Kernel's top competitors include Ceribell, Neuralink and Cala Health. Among them, Neuralink secured the most recent funding round in May, 2026.

Kernel - 2026 Company Profile, Team, Funding & Competitors

Kernel is a series C company based in Los Angeles (United States), founded in 2016. It operates as a Developer of multimodal brain measurement technology for neuromedicine. Kernel has raised $158M in funding from General Catalyst. The company has 148 active competitors, including 45 funded and 17 that have exited. Its top competitors include companies like Ceribell, Neuralink and Cala Health.

Company Details

Developer of multimodal brain measurement technology for neuromedicine. This technology facilitates treatment response prediction by leveraging brain-based biomarkers to improve clinical decision-making and patient outcomes. It also enables translational research by identifying signatures of treatment efficacy and optimizes clinical trials through improved patient stratification and endpoint quantification. The platform offers quick and easy brain measurement for early identification of neurological issues, potentially transforming routine healthcare monitoring. The system is designed for ease of use and provides research-grade results.

Website: www.kernel.com
Social

Key Metrics

Founded Year

2016

Location

Los Angeles, United States

Stage

Series C

Total Funding

$158M in 3 rounds

Latest Funding Round

Series C, Nov 21, 2023, $*****

Investors

General Catalyst & 4 more

Ranked

7^th among 148 active competitors

Employee Count

60 as on Jul 31, 2026

Similar Companies

Ceribell & 181 more

View Kernel's full profile

Kernel has raised a total funding of $158M over 3 rounds. Its first funding round was on Oct 20, 2016. Kernel has 5 institutional investors.

Here is the list of recent funding rounds of Kernel:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 21, 2023	1848831	Series C	2015430	6686268	5704502	4093786
Jul 09, 2020	4456877	Series C	8560745	6286002	2196100	Khosla Ventures & 2 more
Oct 20, 2016	2073643	Angel	3124621	5278070	5715672	3256871

Access funding benchmarks and valuations. Sign up today!

View details of Kernel's funding rounds and investors

Kernel's employee count trend

Kernel has 60 employees as of Jul 26. Here is Kernel's employee count trend over the years:

Uncover Kernel's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kernel include Ceribell, Neuralink and Cala Health. Here is the list of Top 10 competitors of Kernel, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Longitude Capital & 11 others	69/100
2nd	Neuralink 2016, Fremont (United States), Series E	Provider of implantable brain-computer interfaces	$1.29B	Founders Fund, Vy Capital & 37 others	66/100
3rd	Cala Health 2013, Stanford (United States), Series D	Developer of a wearable non-invasive neuromodulation device	$257M	Vertex Growth, Novartis & 29 others	65/100
4th	Openwater 2016, San Francisco (United States), Series C	Provider of imaging technologies for medical diagnosis and treatments	$100M	Khosla Ventures, Bold Capital Partners & 10 others	60/100
5th	BrainScope 2006, Bethesda (United States), Series B	Provider of AI-powered non-invasive medical devices for diagnosing and assessing brain injuries, including concussions and brain bleeds	$62.2M	Maryland Venture Fund, Aon & 11 others	58/100
6th	NeuroOne 2023, Eden Prairie (United States), Public	Developer of minimally invasive thin film electrodes for the diagnosis of neurological conditions	-	-	55/100
7th	Kernel 2016, Los Angeles (United States), Series C	Developer of multimodal brain measurement technology for neuromedicine	$158M	General Catalyst, Khosla Ventures & 3 others	57/100
8th	Wellumio 2019, Wellington (New Zealand), Seed	Provider of MRI-based device for the diagnosis of stroke	$5.15M	Nuance, Icehouse Ventures & 5 others	51/100
9th	NeuroEM 2013, Tampa (United States), Series A	Developer of medical device a non-invasive treatment for cognitive decline	$9M	Bluelake, New York Angels & 1 others	50/100
10th	Mendi 2017, Stockholm (Sweden), Seed	Provider of wearable brain training devices	$8.21M	First Venture, Gaingels & 8 others	50/100